Rapid production of the anaesthetic mepivacaine through continuous, portable technology

Pablo Díaz-Kruik,Francesca Paradisi,Pablo Diaz-Kruik
DOI: https://doi.org/10.1039/d3gc04375d
2024-01-24
RSC Green Chemistry
Abstract:Local anaesthetics such as mepivacaine are key molecules in the medical sector, ensuring the supply chain is crucial for every health care system. Rapid production of mepivacaine from readily available commercial reagents and (non-dry) solvents, under safe conditions through a portable, continuous apparatus could make an impactful difference in underdeveloped countries. In this work we report a continuous platform for synthesising mepivacaine, one of the most widely used anaesthetic for minor surgeries. With a focus on sustainability, reaction efficiency and seamless implementation, this platform afforded the drug in 44% isolated yield following a concomitant distillation-crystallisation, at a gram scale after N-functionalisation and amide coupling, with full recovery of the solvents and excess reagents. The use of flow chemistry as an enabling tool allowed the use of "forbidden" chemistry typically challenging for preparative and large scale reactions in batch mode. Overall, this continuous platform presents a promising and sustainable approach that has the potential to meet the demands of the healthcare industry.
What problem does this paper attempt to address?